Longevity Health Holdings, Inc.
Longevity Health Holdings, Inc. is a U.S.-based bio-aesthetics company focused on longevity and healthy aging. It develops and sells cosmetic skincare and haircare products for professional care providers and retail consumers, while also holding a pipeline of regenerative bone and tissue healing products that has been deprioritized. The company is also pursuing acquisitions and restructuring to concentrate on nearer-term commercial products.
Tilikausi 2025 · muutos edellisvuodesta
Kehitys 2021–2025
Liiketoiminta
Osuus liikevaihdostaSkincare products aimed at skin health, longevity, and professional aesthetic use.
Haircare products sold to support hair health through retail and professional channels.
Company-branded cosmetic products sold directly to end customers online or through owned channels.
Third-party distribution of cosmetic products into broader retail and professional markets.
Bone and tissue healing products and related R&D programs that are currently paused.
Asiakkaat
The company sells primarily in the United States to professional care providers, retail consumers, and distributors. Its products are positioned for customers seeking cosmetic skincare and haircare solutions with a longevity and healthy-aging angle, rather than therapeutic medical treatments. Revenue is currently concentrated in commercial cosmetic products, while the regenerative pipeline is not the main near-term customer driver.
Clinics and other professional users buy skincare and haircare products that meet technical performance requirements.
End consumers buy branded cosmetic products for skin and hair health through direct channels.
Distribution partners buy products for resale and market reach expansion.
Future partners may license or commercialize paused bone and tissue healing programs.
Strategia
Longevity is shifting toward nearer-term commercial cosmetic products and away from longer-dated research programs. Management is also pursuing acquisitions, including the Elevai acquisition and the THPlasma merger, to broaden product capabilities and support future growth. Cost reduction, channel commercialization, and liquidity preservation are central to the current strategy.
These products have the clearest near-term revenue potential and support the company’s repositioning.
The company has negative working capital and operating cash outflows, so cash preservation is essential.
Acquisitions may add product rights, regulatory approvals, and commercial scale.
Licensing can monetize paused programs without requiring heavy internal development spend.
Maantiede
The business is primarily U.S.-focused, with cosmetic product sales generated mainly in the United States. The company has not disclosed a broader international revenue footprint in the provided excerpts, so geographic exposure appears concentrated in one market. That concentration makes U.S. consumer demand, regulatory conditions, and channel execution especially important.
Riskit
The company faces going-concern and liquidity risk because it has negative working capital, operating losses, and negative operating cash flow. Execution risk is elevated because the business is dependent on a small employee base, ongoing restructuring, and pending mergers that could be delayed or fail. As a consumer-facing cosmetics business, it also faces demand, channel, and product adoption risk, while the paused regenerative pipeline adds uncertainty around future monetization.
- THPlasma merger completion riskVaikutus: KorkeaTodennäköisyys: Kohtalainen
The merger is subject to closing conditions and litigation risk, and failure could hurt the strategic plan.
Kohdistuu: M&A execution and future product/regulatory access
- Liquidity and going-concern pressureVaikutus: KorkeaTodennäköisyys: Matala
The company reported negative working capital and negative operating cash flow, limiting flexibility.
Kohdistuu: Cash runway and ability to fund operations
- Dependence on limited personnelVaikutus: KeskitasoTodennäköisyys: Kohtalainen
The company disclosed only ten full-time employees, making retention critical.
Kohdistuu: Operational continuity and public-company reporting
- Commercial adoption risk for cosmetic productsVaikutus: Keskitaso
Revenue depends on continued launch and acceptance of skincare and haircare products.
Kohdistuu: Sales growth and channel performance
Kirjanpito
Harkinnanvaraiset erätGross sales are reduced by discounts and allowances, affecting reported net revenue and margin.
Vaikutus: Gross-to-net deductions
Prior periods included a large fair value loss on the FPA, showing sensitivity to valuation assumptions.
Vaikutus: Other expense and earnings volatility
Negative working capital and cash burn require management judgment about future funding and continuity.
Vaikutus: Liquidity disclosure and asset/liability measurement
Recent and pending acquisitions may create goodwill, intangible assets, and valuation estimates.
Vaikutus: Balance sheet composition and future impairment risk
Samankaltaisia listattuja yhtiöitä
Julkisesti listattuja yhtiöitä, joilla on samankaltainen liiketoiminta.
Hi-Great Group Holding Co
HIGR · Hotels & Motels
Hi-Great Group Holding Co is a development-stage U.S.
SL Science Holding Ltd
SLBT · Biological Products, (No Diagnostic Substances)
SL Science Holding Ltd is a U.S.-listed biotechnology and biological products company based in Taipei, Taiwan, operating through its SL Bio business.
Longduoduo Co Ltd
LDDD · Services-Health Services
Longduoduo Co Ltd is a U.S.-listed company with operating subsidiaries in Inner Mongolia and Beijing that generates revenue from two main activities: direct…
Longeveron Inc.
LGVN · Pharmaceutical Preparations
Visionary Holdings Inc.
GVHGF · Services-Educational Services
Celularity Inc
CELU · Pharmaceutical Preparations
Päivitetty: 24.9.2026